FCA seeks views on increasing access to patient capital in retail funds

Patient capital refers to a broad range of alternative investment assets intended to deliver long-term returns; for example, infrastructure, real estate, private equity/debt and venture capital. These assets are typically illiquid and often require a committed investor willing and able to tie up their capital and forgo on-demand liquidity or an immediate return on their investment.

In 2016, HM Treasury and the Department for Business Energy and Industrial Strategy (BEIS) launched the Patient Capital Review (PCR). The review found that investment in patient capital assets is below its potential and this, in turn, negatively impacts the UK economy.

If you’re not a client, to read this content you must sign up for a free guest account

Clients of threesixty are kept up to speed with the latest regulatory, industry and technical developments via our regular news and opinions articles.

As well as being updated via the articles we publish to threesixty online, clients can specify to us what type of articles they want to receive (by category) and how frequently they receive them.

To try this service, simply register your details with us and we'll give you 3 months free and unlimited access to our news and opinions.